NCT00742963 2025-05-13Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue SarcomaImmunoGenesisPhase 1/2 Completed107 enrolled 7 charts
NCT01440088 2016-06-02A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue SarcomaThreshold PharmaceuticalsPhase 3 Completed640 enrolled